文献速递肥胖与代谢综合征

代谢健康型肥胖真的存在吗:迈向新定义

Does metabolically healthy obesity really exist: going toward new definitions.
PubMed 文献 · J Clin Endocrinol Metab · 2026-01-01

本文通过叙述性综述回顾PubMed索引的肥胖表型研究,结合Lancet委员会提出的临床前与临床肥胖框架,指出代谢健康型肥胖因定义不一致、依赖心血管代谢危险因素及长期稳定性差而受限,建议以基于器官功能障碍的连续性疾病框架替代二元代谢表型。

要点

  • 代谢健康型肥胖定义不一致且长期稳定性差,临床价值有限。
  • 新框架区分临床前肥胖(脂肪过多但器官功能保留)与临床肥胖(伴器官功能障碍)。
  • 基于器官功能障碍的连续框架有助于风险分层与治疗优先。

核心结论

  • 用Lancet委员会提出的临床前与临床肥胖框架替代二元代谢表型,可提供有生物学依据且临床可操作的模型。

研究设计与样本

  • 叙述性综述,检索PubMed索引的肥胖表型研究,优先选择大型流行病学队列和详细表型分析的机制研究。

主要发现

  • 代谢健康型肥胖概念受限于定义不一致、依赖心血管代谢危险因素及长期稳定性差。
  • 新兴证据支持转向区分临床前肥胖(脂肪过多但器官和组织功能保留)与临床肥胖(伴器官功能障碍)的疾病框架。

临床怎么用

  • 采用基于连续性和功能导向的方法可能改善风险分层、指导治疗优先次序并减少对「良性」肥胖的误解。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

CONTEXT: Obesity is a heterogeneous chronic disease traditionally defined by body mass index, yet individuals with similar body mass index values can exhibit substantial variability in the presence of cardiometabolic risk factors independent of adiposity. Such discordance has led to the concept of "metabolically healthy obesity," describing individuals with excess adiposity but without overt metabolic abnormalities. However, the validity and clinical relevance of metabolically healthy obesity remain controversial. EVIDENCE ACQUISITION: We conducted a narrative review of PubMed-indexed studies examining obesity phenotypes considering the recent preclinical/clinical obesity framework proposed by the Lancet Commission on Diabetes and Endocrinology. Preference was given for large epidemiological cohorts and mechanistic studies with detailed phenotyping. EVIDENCE SYNTHESIS: The metabolically healthy obesity concept is limited by inconsistent definitions, reliance on cardiometabolic risk factors, and poor long-term stability. Emerging evidence supports a shift toward a disease-based framework distinguishing preclinical obesity (excess adiposity with preserved organ and tissue function) from clinical obesity which is associated with organ dysfunction. CONCLUSION: Replacing binary metabolic phenotypes with the preclinical and clinical obesity framework proposed by the Lancet Commission provides a biologically grounded, clinically actionable model that aligns obesity classification with organ dysfunction and disease progression. Adopting a continuum-based, function-oriented approach may improve risk stratification, guide therapeutic prioritization, and reduce misconceptions surrounding "benign" obesity.

来源:J Clin Endocrinol Metab,查看原文。版权归原作者所有。

引用

  1. Rodriguez C, Ravussin E. Does metabolically healthy obesity really exist: going toward new definitions. J Clin Endocrinol Metab. 2026. PMID: 42338427. doi:10.1210/clinem/dgag247

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。